Navigation Links
uniQure Licenses RNA Interference Technology to Advance Huntington's Disease Program
Date:12/5/2012

AMSTERDAM, The Netherlands, December 5, 2012 /PRNewswire/ --

uniQure B.V., a leader in the field of human gene therapy, today announced a non-exclusive cross-licensing agreement with Benitec Biopharma Ltd. (ASX: BLT) giving uniQure access to Benitec's proprietary DNA-directed RNA interference (ddRNAi) technology in Huntington's disease. In return, uniQure granted Benitec non-exclusive access to the Company's AAV5 delivery technology for the development of a ddRNAi therapy for Hepatitis B.

"The cross-licensing agreement with Benitec fully capitalizes on the strength of our advanced AAV platform and our proven ability to deliver therapeutic genes to target cells with high accuracy and efficacy," says Jörn Aldag, CEO of uniQure.  "The agreement with Benitec opens up promising new avenues to develop therapies for high unmet medical needs such as Huntington's disease. While our current programs focus on delivering fully functioning therapeutic genes to remedy faulty or malfunctioning genes, Benitec's ddRNAi technology will allow us to do the opposite - to 'silence' the gene responsible for producing the mutant protein that lies at the basis of Huntington's disease, and to develop a therapy for this devastating disease."

Dr Peter French, CEO of Benitec Biopharma, commented, "Benitec Biopharma is very pleased to have executed this licensing agreement with uniQure, the first company to achieve market approval for a gene therapy product, Glybera, in the West. uniQure have demonstrated their unique ability to take gene therapy-based programs from pre-clinical stages to commercialization, and we are confident that they will be able to achieve a similar outcome in this program. Importantly this agreement also provides Benitec access to uniQure's AAV delivery technology enabling further development of our ddRNAi treatment for Hepatitis B."

About Huntington's disease

Huntington's disease (HD) is a rare, chronic, incurable, progressi
'/>"/>

SOURCE uniQure B.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MetaStat, Inc. Executes Two New Licenses
2. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
3. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
4. NTT DATA Licenses DATATRAK ONE™ for China
5. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
6. West Health Institute licenses Kinect-based physical therapy technology to Reflexion Health; West Health Investment Fund makes $4.25 million investment
7. Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
10. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
11. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... for Zalviso remains July 27, 2014.  The ... the Food and Drug Administration (FDA) had approved Zalviso.  ... notification to the company from the FDA regarding the ...
(Date:7/24/2014)... PLAINFIELD, N.J. , July 24, 2014  PTC ... that the Company will host a webcast conference call ... provide an update on the company,s business and outlook ... before the opening of the market. ... (domestic) or (973) 935-8152 (international) five minutes prior to ...
(Date:7/24/2014)... , Deutschland, und MARSEILLE ... -- , Weltweite ... ermöglicht QIAGEN die Entwicklung von Tests ... für Blutkrebs  Neuer Test weist ... mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf ...
Breaking Medicine Technology:AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
(Date:7/25/2014)... 25, 2014 (HealthDay News) -- Seniors are more easily ... a new study finds. "Almost any type of ... the age of 25 on," study co-author Randi Martin, ... university news release. However, Martin said, this study ... processing in older adults compared with younger adults. ...
(Date:7/25/2014)... As reported by People Magazine in the article ... and Getting Sober (7/15), one of the most popular ... out to the public about his personal transformation. Now, two ... admits that moving on with his life was a challenge. ... drugs in 2012 and even spent some time in rehab. ...
(Date:7/25/2014)... CA (PRWEB) July 25, 2014 AttorneyOne.com, a ... the latest information from the FDA on Ibuprofen and ... 21, that one lot of Ibuprofen and one lot of ... due to mislabeled packaging. Oxcarbazepine is used for the ... , The reason for the recall is that ...
(Date:7/25/2014)... July 25, 2014 Parker Waichman LLP, ... of consumers comments on a recent tobacco lawsuit in ... smoker $23.6 billion in punitive damages. Cynthia Robinson brought ... cigarettes. The case is Cynthia Robinson v. R.J. Reynolds ... Florida First Circuit Court, Escambia County, Florida; Case Number ...
(Date:7/25/2014)... Drexel University College of Medicine ... FACP, has been appointed vice dean for education, effective October ... The Commonwealth Medical College, where she is currently chair of ... and professor of medicine. , As a member of ... had a major role in many aspects of the development ...
Breaking Medicine News(10 mins):Health News:Distractions Seem More Troublesome With Age 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3
... dogs in metropolitan cities killing small children and following this ... hundreds of animal lovers. // ,Recently it was reported ... Hyderabad. Authorities had caught about 22,000 dogs last year. ... to an uproar with animal rights activists saying there are ...
... are looking for the perfect partner in life, forget about ... ,Researchers at Manchester University in northern Britain said they ... that the zodiac had no impact on chances of marrying ... released Monday. ,The investigation used census data from ...
... To celebrate the silver jubilee of The Art of Living ... stress free' America initiative;// is being launched by Indian spiritual ... likely to be attended by over 2,500 people along with ... programmes to foster human values such as compassion, friendliness, a ...
... Researchers at the University of California, San Diego (UCSD) ... seemingly healthy subjects //is associated with increased clotting of ... cardiovascular disease. The findings were published in the March ... College of Chest Physicians. ,'In previous work, ...
... Illness related to C. difficile, a bacterium commonly found in ... treat,// reports the April 2007 issue of Harvard Women’s Health ... strain may be to blame. ,Certain strains of ... colon. Those strains can cause symptoms ranging from mild diarrhea ...
... "crystal") and other amphetamines on,already stretched// public hospital ... physicians,and drug specialists have warned in the latest ... to beef up health and social drug intervention ... that a significant number of patients are presenting ...
Cached Medicine News:Health News:Animal Lovers Protest Brutal Dog Killings 2Health News:Emergency Department Strain As Ice Problems Grows 2Health News:Emergency Department Strain As Ice Problems Grows 3
... The low-profile 5107 Bariatric Stand-On Scale is ... lbs, while typical physicians scales only weigh ... regardless of floor surface, or patients position ... stable and low profile only 1 ...
... hormone (PTH) is synthesized by the ... response to decreased extracellular calcium concentrations. ... resorption and decreasing calcium excretion by ... circulation, intact PTH is rapidly degraded ...
... the adrenal cortex and, to a lesser ... a precursor in testosterone and estrogen synthesis, ... at ~10% that of testosterone [1]. However, ... women, DHEA is an important androgen as ...
... a C19 steroid, is one of the ... postpubertal males, testosterone is secreted primarily by ... derived from peripheral conversion of androstenedione [2]. ... that over 50% of serum testosterone is ...
Medicine Products: